glp 1 drugs and bipolar disorder Glucagon-like peptide-1 receptor agonists risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study An analysis on the role
Description
examined GLP-1R expression in prostate cancer cell lines and tissue samples from men and found that Exenatide might suppress the activation of ERK and MAPK, therefore reducing the progression of prostate cancer [143]

doi: 10.1016/j.tem.2018.08.005 55 HoegerKMDokrasAPiltonenT

However, some patients experience significant side effects, including nausea, vomiting, or gastrointestinal discomfort

Some anti-diabetic medications are linked with an increased risk of weight gain or hypoglycemia which may reduce the efficacy of the intended anti-hyperglycemic effects of these therapies
Furthermore, Lixisenatide has a low incidence of side effects, with the most prevalent ones being vomiting and nausea [239], [240]
but they do provide limited coverage for bariatric surgery and intensive behavioral therapy for weight loss for those who qualify
